| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
34,305 |
30,484 |
$2.46M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
13,738 |
10,666 |
$1.90M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
25,762 |
22,332 |
$1.40M |
| 80053 |
Comprehensive metabolic panel |
39,595 |
31,184 |
$1.18M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,601 |
9,634 |
$874K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
10,854 |
6,152 |
$762K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
13,885 |
12,119 |
$704K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,115 |
4,201 |
$488K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,634 |
1,461 |
$476K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
51,222 |
38,134 |
$444K |
| 29581 |
|
8,632 |
1,890 |
$413K |
| 70450 |
Computed tomography, head or brain; without contrast material |
6,172 |
5,429 |
$412K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
8,673 |
6,422 |
$390K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,290 |
4,162 |
$379K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
5,506 |
4,939 |
$375K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,539 |
4,751 |
$274K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,462 |
2,758 |
$249K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,661 |
1,623 |
$241K |
| G0378 |
Hospital observation service, per hour |
4,661 |
3,639 |
$240K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,573 |
4,008 |
$230K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,569 |
2,601 |
$218K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,246 |
2,499 |
$216K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,912 |
2,788 |
$210K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
4,634 |
3,580 |
$203K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
8,297 |
6,437 |
$202K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,920 |
1,757 |
$188K |
| 80306 |
|
4,231 |
3,830 |
$187K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,410 |
2,188 |
$179K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
889 |
812 |
$163K |
| 99215 |
Prolong outpt/office vis |
1,677 |
1,171 |
$148K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,211 |
1,116 |
$141K |
| 81025 |
|
10,631 |
9,489 |
$136K |
| 59025 |
Fetal non-stress test |
1,718 |
1,277 |
$126K |
| 81001 |
|
21,574 |
18,789 |
$120K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,827 |
1,654 |
$117K |
| 84484 |
|
11,325 |
8,502 |
$114K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,806 |
2,607 |
$112K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,986 |
2,727 |
$110K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,842 |
1,466 |
$108K |
| 96367 |
|
1,943 |
1,233 |
$105K |
| 87430 |
|
3,571 |
3,331 |
$103K |
| 87081 |
|
2,330 |
2,144 |
$101K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,527 |
5,817 |
$97K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,809 |
2,614 |
$97K |
| 97597 |
|
2,707 |
1,601 |
$81K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
595 |
536 |
$81K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,958 |
1,766 |
$76K |
| 82728 |
|
3,264 |
2,781 |
$65K |
| 87210 |
|
2,485 |
2,297 |
$60K |
| 96415 |
|
718 |
518 |
$58K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,651 |
4,725 |
$58K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,399 |
2,155 |
$57K |
| 70496 |
|
927 |
822 |
$57K |
| 83690 |
|
9,905 |
8,524 |
$55K |
| 87077 |
|
3,153 |
2,577 |
$54K |
| 87070 |
|
1,685 |
1,433 |
$52K |
| 87486 |
|
1,631 |
1,461 |
$52K |
| 70498 |
|
909 |
808 |
$51K |
| 93971 |
|
1,344 |
1,242 |
$45K |
| 87581 |
|
1,631 |
1,461 |
$44K |
| 84702 |
|
1,426 |
1,249 |
$40K |
| 36430 |
|
364 |
237 |
$40K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
19,583 |
15,601 |
$39K |
| G0379 |
Direct admission of patient for hospital observation care |
908 |
757 |
$37K |
| 83735 |
|
6,511 |
5,020 |
$35K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
534 |
494 |
$34K |
| 87040 |
|
5,237 |
2,721 |
$34K |
| 86850 |
|
2,914 |
2,408 |
$32K |
| 85610 |
|
6,187 |
5,104 |
$31K |
| 83605 |
|
4,306 |
3,190 |
$31K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16,261 |
11,225 |
$31K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
435 |
402 |
$30K |
| 82565 |
|
1,904 |
1,598 |
$30K |
| 83880 |
|
1,586 |
1,366 |
$29K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
484 |
442 |
$28K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,540 |
6,404 |
$28K |
| 94664 |
|
1,652 |
1,487 |
$28K |
| 93017 |
|
812 |
733 |
$26K |
| 85027 |
|
2,878 |
2,381 |
$25K |
| 12001 |
|
306 |
283 |
$25K |
| 85379 |
|
3,005 |
2,706 |
$25K |
| 87807 |
|
1,172 |
1,108 |
$25K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
266 |
246 |
$23K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
47 |
39 |
$23K |
| 84145 |
|
1,438 |
1,212 |
$23K |
| 71046 |
Radiologic examination, chest; 2 views |
4,049 |
3,678 |
$22K |
| 87186 |
|
2,947 |
2,429 |
$20K |
| 95806 |
|
482 |
442 |
$18K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,669 |
1,439 |
$17K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
82 |
80 |
$16K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
38 |
36 |
$15K |
| 0042T |
|
362 |
321 |
$15K |
| 86140 |
|
3,463 |
2,602 |
$13K |
| 85730 |
|
3,344 |
2,888 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
276 |
242 |
$12K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
42 |
38 |
$12K |
| 87088 |
|
2,127 |
1,792 |
$11K |
| 76830 |
Ultrasound, transvaginal |
245 |
218 |
$11K |
| 80076 |
|
490 |
428 |
$10K |
| 72141 |
|
140 |
129 |
$9K |
| 12011 |
|
72 |
69 |
$8K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
12 |
12 |
$8K |
| 86900 |
|
3,234 |
2,705 |
$8K |
| 29125 |
|
122 |
115 |
$8K |
| 84100 |
|
2,197 |
1,456 |
$8K |
| 82805 |
|
313 |
264 |
$8K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
89 |
81 |
$8K |
| 80050 |
General health panel |
2,170 |
1,978 |
$8K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
18 |
15 |
$7K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
41 |
39 |
$7K |
| 86901 |
|
3,236 |
2,706 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
11,634 |
10,183 |
$7K |
| 84132 |
|
369 |
282 |
$7K |
| 36902 |
|
28 |
24 |
$6K |
| 86923 |
|
222 |
149 |
$6K |
| 96409 |
|
347 |
198 |
$6K |
| 83550 |
|
1,125 |
990 |
$6K |
| 85652 |
|
3,130 |
2,377 |
$6K |
| 93458 |
|
12 |
12 |
$5K |
| 95800 |
|
114 |
106 |
$5K |
| 70486 |
|
145 |
135 |
$5K |
| 90715 |
|
758 |
712 |
$5K |
| 83540 |
|
1,167 |
1,025 |
$5K |
| 97605 |
|
67 |
12 |
$5K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,200 |
14,714 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
306 |
275 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
41 |
40 |
$4K |
| 71250 |
|
134 |
122 |
$4K |
| 84439 |
|
293 |
263 |
$4K |
| 80061 |
Lipid panel |
298 |
266 |
$4K |
| 82550 |
|
683 |
468 |
$3K |
| 89051 |
|
38 |
24 |
$3K |
| 74018 |
|
1,127 |
1,023 |
$3K |
| 84703 |
|
301 |
272 |
$3K |
| 90686 |
|
273 |
238 |
$3K |
| 93922 |
|
98 |
90 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
293 |
257 |
$3K |
| 93225 |
|
99 |
91 |
$2K |
| 85007 |
|
150 |
127 |
$2K |
| 95700 |
|
12 |
12 |
$2K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
13 |
$2K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
52 |
48 |
$2K |
| 76770 |
|
33 |
31 |
$2K |
| 72197 |
|
14 |
13 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
29 |
27 |
$1K |
| 96417 |
|
61 |
36 |
$1K |
| 82784 |
|
132 |
103 |
$1K |
| 73630 |
|
1,618 |
1,403 |
$1K |
| 12002 |
|
17 |
15 |
$1K |
| 70491 |
|
16 |
14 |
$1K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
13 |
12 |
$1K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,439 |
2,757 |
$1K |
| 93970 |
|
27 |
26 |
$960.80 |
| 96523 |
|
13 |
12 |
$926.40 |
| 83615 |
|
135 |
104 |
$889.54 |
| 72100 |
|
378 |
345 |
$883.36 |
| 86308 |
|
30 |
26 |
$807.61 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
673 |
520 |
$790.35 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
25 |
24 |
$664.40 |
| 85045 |
|
203 |
171 |
$624.82 |
| G0008 |
Administration of influenza virus vaccine |
319 |
283 |
$555.20 |
| 93226 |
|
99 |
91 |
$447.03 |
| 96376 |
|
3,026 |
2,142 |
$433.79 |
| 73610 |
|
1,046 |
936 |
$416.15 |
| 99152 |
|
2,473 |
2,150 |
$402.25 |
| 88307 |
|
232 |
156 |
$378.23 |
| 87075 |
|
89 |
82 |
$360.41 |
| 82272 |
|
42 |
37 |
$355.01 |
| 82607 |
|
59 |
52 |
$333.25 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
13 |
$288.96 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
25,702 |
19,047 |
$284.46 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
760 |
676 |
$279.82 |
| 36415 |
Collection of venous blood by venipuncture |
7,387 |
5,714 |
$265.09 |
| 82570 |
|
51 |
39 |
$223.80 |
| 76870 |
|
13 |
12 |
$221.25 |
| 87205 |
|
78 |
68 |
$217.47 |
| 82150 |
|
41 |
30 |
$217.10 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
21 |
15 |
$180.48 |
| 84156 |
|
56 |
38 |
$179.47 |
| 36591 |
|
853 |
566 |
$159.64 |
| 82009 |
|
49 |
41 |
$150.84 |
| 72170 |
|
376 |
323 |
$144.16 |
| 86780 |
|
13 |
13 |
$140.01 |
| 76937 |
|
87 |
72 |
$109.38 |
| 73030 |
|
756 |
673 |
$103.29 |
| 90656 |
|
13 |
13 |
$90.39 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
608 |
549 |
$75.48 |
| J3490 |
Unclassified drugs |
16,787 |
7,651 |
$71.26 |
| 84550 |
|
14 |
12 |
$63.52 |
| 73562 |
|
825 |
711 |
$58.50 |
| 85018 |
|
29 |
26 |
$47.45 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,426 |
3,000 |
$46.43 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16,925 |
11,857 |
$43.51 |
| 74019 |
|
134 |
123 |
$42.61 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
545 |
508 |
$41.02 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
1,417 |
1,297 |
$41.01 |
| 88304 |
|
271 |
217 |
$24.95 |
| 97535 |
Self-care/home management training, each 15 minutes |
28 |
12 |
$20.93 |
| 72040 |
|
15 |
13 |
$18.44 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,707 |
9,591 |
$18.23 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
3,400 |
2,433 |
$17.36 |
| 73140 |
|
43 |
38 |
$16.88 |
| A9270 |
Non-covered item or service |
3,841 |
2,499 |
$13.27 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
4,945 |
3,795 |
$12.05 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,306 |
8,484 |
$10.43 |
| 88312 |
|
741 |
523 |
$9.81 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,028 |
9,466 |
$9.41 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,457 |
3,319 |
$9.06 |
| 73502 |
|
137 |
120 |
$8.64 |
| 73130 |
|
495 |
432 |
$8.44 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
18,853 |
13,872 |
$8.42 |
| 88313 |
|
151 |
109 |
$7.83 |
| 99153 |
Mod sedat endo service >5yrs |
1,764 |
1,534 |
$7.33 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
161 |
149 |
$6.39 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,901 |
1,651 |
$5.37 |
| 88342 |
|
26 |
24 |
$5.37 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,440 |
7,642 |
$5.16 |
| C1729 |
Catheter, drainage |
65 |
63 |
$3.44 |
| C1769 |
Guide wire |
2,200 |
1,947 |
$3.37 |
| J2704 |
Injection, propofol, 10 mg |
13,347 |
7,620 |
$2.51 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
94 |
87 |
$2.50 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
616 |
227 |
$2.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
672 |
584 |
$1.95 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,037 |
2,332 |
$1.63 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,653 |
5,383 |
$1.47 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
154 |
89 |
$0.92 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
298 |
270 |
$0.72 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
51 |
40 |
$0.70 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
3,437 |
2,687 |
$0.30 |
| J1644 |
Injection, heparin sodium, per 1000 units |
3,058 |
1,606 |
$0.21 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
478 |
390 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,071 |
807 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,899 |
2,980 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
346 |
294 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
693 |
612 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
883 |
668 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
534 |
463 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,287 |
3,507 |
$0.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
191 |
123 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
353 |
319 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
1,533 |
1,307 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
193 |
171 |
$0.00 |
| 71101 |
|
44 |
43 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
17 |
15 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
60 |
44 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
248 |
187 |
$0.00 |
| 36416 |
|
165 |
136 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
92 |
73 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
16 |
13 |
$0.00 |
| 80349 |
|
16 |
14 |
$0.00 |
| 94644 |
|
16 |
12 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
814 |
408 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
186 |
127 |
$0.00 |
| J9370 |
Vincristine sulfate, 1 mg |
97 |
76 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,262 |
1,506 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
787 |
706 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
154 |
121 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
210 |
90 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
783 |
650 |
$0.00 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
107 |
94 |
$0.00 |
| 73110 |
|
294 |
269 |
$0.00 |
| 73080 |
|
86 |
79 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
262 |
241 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
73 |
50 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
272 |
236 |
$0.00 |
| 73590 |
|
82 |
69 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
233 |
131 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
44 |
39 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
27 |
24 |
$0.00 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
55 |
48 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
33 |
27 |
$0.00 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
41 |
37 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
29 |
24 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
15 |
13 |
$0.00 |